Citadel Advisors
TRVI icon

Citadel Advisors’s Trevi Therapeutics TRVI Stock Holding History

Citadel Advisors’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
105,100
+52,200
+99% +$584K ﹤0.01% 7164
2025
Q4 		$662K Buy
52,900
+8,100
+18% +$93.6K ﹤0.01% 8335
2025
Q3 		$410K Sell
44,800
-153,800
-77% -$1.15M ﹤0.01% 9614
2025
Q2 		$1.09M Buy
198,600
+90,400
+84% +$562K ﹤0.01% 6914
2025
Q1 		$681K Buy
108,200
+91,000
+529% +$434K ﹤0.01% 7802
2024
Q4 		$70.9K Buy
17,200
+16,600
+2,767% +$53.1K ﹤0.01% 11945
2024
Q3 		$2K Buy
+600
New +$1.78K ﹤0.01% 13789
2024
Q2 		– Sell
-2,200
Closed -$7.59K – 15427
2024
Q1 		$7.59K Buy
2,200
+400
+22% +$893 ﹤0.01% 13607
2023
Q4 		$2.41K Buy
+1,800
New +$2.73K ﹤0.01% 13702
2023
Q3 		– Sell
-1,000
Closed -$2.39K – 15129
2023
Q2 		$2.39K Sell
1,000
-100
-9% -$252 ﹤0.01% 13788
2023
Q1 		$2.04K Sell
1,100
-100
-8% -$226 ﹤0.01% 14216
2022
Q4 		$2.32K Buy
+1,200
New +$2.37K ﹤0.01% 14352

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return